News Agency
Men's Weekly

TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China

  • Written by PR Newswire

-  Hansoh plans to develop 'TU2670 (Hansoh's code: HS-10518)' as a best-in-class novel GnRH antagonist in China-  TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year

BOSTON and SEONGNAM, South Korea, July 5, 2023 /PRNewswire/ -- TiumBio Co., Ltd. (KOSDAQ:...

Read more: TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China

Australian Workplaces 2026: Why Office Furniture Stools Are Gaining Ground in Modern Design

Sydney, Australia — 2026 — As Australian workplaces continue to evolve at a rapid pace, a once-overlooked piece of furniture is stepping into the spotlight: the stool. From drafting stools in design studios to height-adjustable seating in schools and laboratories... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion